{"id":"https://openalex.org/W7225834093","doi":"https://doi.org/10.18609/cgti.2026.132","title":"Industry Insights: Base editing nears its first BLA as AAV safety comes under scrutiny","display_name":"Industry Insights: Base editing nears its first BLA as AAV safety comes under scrutiny","publication_year":2026,"publication_date":"2026-11-11","ids":{"openalex":"https://openalex.org/W7225834093","doi":"https://doi.org/10.18609/cgti.2026.132"},"language":"en","primary_location":{"id":"doi:10.18609/cgti.2026.132","doi":"https://doi.org/10.18609/cgti.2026.132","is_oa":true,"landing_page_url":"https://doi.org/10.18609/cgti.2026.132","pdf_url":null,"source":{"id":"https://openalex.org/S4210198480","display_name":"Cell and Gene Therapy Insights","issn_l":"2059-7800","issn":["2059-7800","2397-0545"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell and Gene Therapy Insights","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.18609/cgti.2026.132","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5120768221","display_name":"Abigail Pinchbeck","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Abigail Pinchbeck","raw_affiliation_strings":["Cell & Gene Therapy Insights"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cell & Gene Therapy Insights","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5120768221"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":"10","first_page":"1059\u20131064","last_page":"1059\u20131064"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.6977999806404114,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.6977999806404114,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.17260000109672546,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","score":0.09769999980926514,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C2776050585","wikidata":"https://www.wikidata.org/wiki/Q7439360","display_name":"Scrutiny","level":2,"score":0.6930000185966492},{"id":"https://openalex.org/C108170787","wikidata":"https://www.wikidata.org/wiki/Q3951828","display_name":"Agency (philosophy)","level":2,"score":0.5684000253677368},{"id":"https://openalex.org/C144501496","wikidata":"https://www.wikidata.org/wiki/Q5533489","display_name":"Genome editing","level":4,"score":0.5465999841690063},{"id":"https://openalex.org/C2780560020","wikidata":"https://www.wikidata.org/wiki/Q79719","display_name":"License","level":2,"score":0.519599974155426},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4674000144004822},{"id":"https://openalex.org/C2776957806","wikidata":"https://www.wikidata.org/wiki/Q4895105","display_name":"Interim","level":2,"score":0.45210000872612},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4357999861240387},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3116999864578247},{"id":"https://openalex.org/C177264268","wikidata":"https://www.wikidata.org/wiki/Q1514741","display_name":"Set (abstract data type)","level":2,"score":0.303600013256073},{"id":"https://openalex.org/C42058472","wikidata":"https://www.wikidata.org/wiki/Q810214","display_name":"Base (topology)","level":2,"score":0.2962999939918518},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.289000004529953},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.27790001034736633},{"id":"https://openalex.org/C110354214","wikidata":"https://www.wikidata.org/wiki/Q6314146","display_name":"Engineering management","level":1,"score":0.2770000100135803},{"id":"https://openalex.org/C39549134","wikidata":"https://www.wikidata.org/wiki/Q133080","display_name":"Public relations","level":1,"score":0.26820001006126404},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2669000029563904},{"id":"https://openalex.org/C61521584","wikidata":"https://www.wikidata.org/wiki/Q705899","display_name":"Accreditation","level":2,"score":0.25459998846054077},{"id":"https://openalex.org/C110875604","wikidata":"https://www.wikidata.org/wiki/Q75","display_name":"The Internet","level":2,"score":0.2529999911785126}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.18609/cgti.2026.132","doi":"https://doi.org/10.18609/cgti.2026.132","is_oa":true,"landing_page_url":"https://doi.org/10.18609/cgti.2026.132","pdf_url":null,"source":{"id":"https://openalex.org/S4210198480","display_name":"Cell and Gene Therapy Insights","issn_l":"2059-7800","issn":["2059-7800","2397-0545"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell and Gene Therapy Insights","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.18609/cgti.2026.132","doi":"https://doi.org/10.18609/cgti.2026.132","is_oa":true,"landing_page_url":"https://doi.org/10.18609/cgti.2026.132","pdf_url":null,"source":{"id":"https://openalex.org/S4210198480","display_name":"Cell and Gene Therapy Insights","issn_l":"2059-7800","issn":["2059-7800","2397-0545"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell and Gene Therapy Insights","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"This":[0],"month,":[1],"Beam":[2],"Therapeutics":[3],"reported":[4],"positive":[5],"topline":[6],"pivotal":[7],"data":[8],"for":[9,29,76],"the":[10,24,66,69,91],"base-edited":[11],"autologous":[12],"cell":[13,18],"therapy":[14,33,36],"risto-cel":[15],"in":[16,37],"sickle":[17],"disease,":[19],"supporting":[20],"what":[21],"would":[22],"be":[23],"first":[25],"Biologics":[26],"License":[27],"Application":[28],"a":[30,74],"base":[31],"editing":[32,79],"[1].":[34],"CAR-T":[35],"autoimmune":[38],"disease":[39],"continued":[40],"to":[41,84,100],"generate":[42],"data,":[43],"with":[44],"Cabaletta,":[45],"Fate,":[46],"and":[47,53,61,90,107,110,114],"Bristol":[48],"Myers":[49],"Squibb":[50],"reporting":[51],"one-year":[52],"interim":[54],"results":[55],"across":[56],"myositis,":[57],"lupus,":[58],"systemic":[59],"sclerosis,":[60],"multiple":[62],"sclerosis":[63],"[2\u20134].":[64],"On":[65],"regulatory":[67],"side,":[68],"US":[70],"FDA":[71],"set":[72],"out":[73],"framework":[75],"individualized":[77],"genome":[78],"products":[80],"while":[81],"CMS":[82],"plans":[83],"broaden":[85],"its":[86],"access":[87],"model":[88],"[10],":[89],"agency":[92],"opened":[93],"an":[94],"investigation":[95],"into":[96],"insertional":[97],"oncogenesis":[98],"linked":[99],"onasemnogene":[101],"abeparvovec":[102],"[14].In":[103],"this":[104],"issue:Clinical":[105],"trials":[106],"research":[108],"Collaborations":[109],"partnerships":[111],"Regulatory":[112],"changes":[113],"updates":[115],"Market":[116],"trends":[117]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-11-12T00:00:00"}